newsfilter
← Latest News
GlobeNewswire·

Century Therapeutics to Attend 2026 Jefferies Global Healthcare Conference in London

  • Century Therapeutics (NASDAQ: IPSC) will attend the 2026 Jefferies Global Healthcare Conference in London on November 18, 2026.
  • Interested parties can schedule 1x1 meetings with the Century Therapeutics team by contacting their respective Jefferies representative.
  • Century Therapeutics is developing iPSC-derived cell therapies for type 1 diabetes, other autoimmune diseases, & cancer.
  • The company's therapies utilize its iPSC cell foundry & Allo-Evasion™ immune evasion engineering technology to create off-the-shelf treatments.
  • Century Therapeutics aims to expand patient access & provide advantages over existing cell therapies to advance the course of care.